Enable R&D by Harnessing ML’s Potential for Biological Data

Find mission-critical datasets on Polly harmonized with 99% accuracy and metadata completeness.

Scale data harmonization for 25+ data types (multi-omics, assay and clinical) from both public and in-house data sources.

Use ML-ready datasets on Polly and match indications to targets 75% faster.

Process data at scale with custom pipelines (30+ ETL pipelines built on Polly) and get analysis-ready data delivered complete with APIs.

Derive deeper insights with ML-ready data curated 10x faster than industry standards and at state-of-the-art costs.

Enable R&D by Harnessing ML’s Potential for Biological Data

Book a demo
Thank you for reaching out!

Our team will get in touch with you over email within next 24-48hrs.
Oops! Something went wrong while submitting the form.

Join 100s of Scientists In Using Polly to Fast-track R&D.

What Our Business Partners Have to Say

Data processing and scientific reporting of metabolomics data are crucial but also tedious. Polly’s range of applications helped our team in accelerating these processes significantly and effectively

Dewakar Sangaraju,
Senior Scientist; Genentech

Extremely impressed by Polly and its power to digest and integrate large datasets. The unique partnership that we have allows us to work hand-in-hand with software engineers and scientists to rapidly develop novel hypotheses that we can test in the lab...

Dr. Kate Yen,
Founder & CEO @Auron Therapeutics

Data analysis is the biggest bottleneck for metabolomics research. Elucidata has worked directly with us to streamline our analysis pipeline, accelerating the pace of our research.

Dr. Russel Jones,
Lead Investigator Van Andel Institute

We really were pleasantly surprised because this tool [El-MAVEN] is really useful in fast analysis of tracer data. It allows us to really look at a broad set of targets so you are not limited anymore for data analysis. A data analyst of mine stepped up to me and said, "I can do now in 3 hours what used to take 4 days.

Bart Ghesquière,
Head of Metabolomics Core Facility @VIB

We were looking for public data on a tight deadline to make decisions on our back up targets for solid tumors. Elucidata was able to understand our relevance criteria, identify, and deliver high-quality harmonized data ahead of schedule. We are really happy with their deliveries and this partnership.

Ming 'Tommy' Tang,
Director of Computational Biology,
Immunitas Therapeutics